Skip to content
Search

Latest Stories

Law firm Brabners welcomes Thorrun Govind to the regulatory team

Law firm Brabners welcomes Thorrun Govind to the regulatory team
Thorrun Govind's new appointment signals support amidst crucial year for independent pharmacy sector

Thorrun Govind, a former chair of the English Pharmacy Board of the Royal Pharmaceutical Society, has joined Brabners' regulatory & professional conduct team.

With nearly a decade of experience as a GPhC-registered pharmacist, Govind will provide guidance on regulatory and professional conduct issues.


Govind's expertise extends to healthcare advisory and disputes involving NHS Trusts and social care organisations.

She has been recognised as the 'Young Pharmacist of the Year' by Pharmacy Business Magazine and is a frequent commentator on public health and healthcare law for major television networks.

Her appointment underscores Brabners' commitment to offering top-tier legal services to the healthcare industry.

Richard Hough, Head of Healthcare at Brabners, expressed confidence in Govind's abilities and highlighted the firm's dedication to supporting healthcare professionals.

"Thorrun's appointment underscores our commitment to offering top-tier legal services to the healthcare industry," says Richard Hough, Head of Healthcare at Brabners.

"Her knowledge as a practising pharmacist makes her a passionate advocate for her clients – something I’m in no doubt will be to the benefit of the wide array of professionals that our regulatory and healthcare teams represent."

Govind emphasised her eagerness to contribute to Brabners' mission of driving positive change in the healthcare sector, stating:

"The independent pharmacy sector faces a critical year as we await the terms of the government’s next contractual framework, M&A activity continues apace and individuals continue to defend their right to practise."

“Central to my decision to join Brabners was the opportunity to support clients in all these areas as part of a firm that’s committed to bringing about positive change."

"It’s been a pleasure to see the team in action already as we look to help clients manage both the expected and unexpected in healthcare,” she added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less